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Background: There is growing evidence suggesting that prolonged sitting has negative effects on people’s weight,
chronic diseases and mortality. Interventions to reduce sedentary time can be an effective strategy to increase daily
energy expenditure. The purpose of this study is to evaluate the effectiveness of a six-month primary care intervention
to reduce daily of sitting time in overweight and mild obese sedentary patients.
Method/Design: The study is a randomized controlled trial (RCT). Professionals from thirteen primary health care
centers (PHC) will randomly invite to participate mild obese or overweight patients of both gender, aged between 25
and 65 years old, who spend 6 hours at least daily sitting. A total of 232 subjects will be randomly allocated to an
intervention (IG) and control group (CG) (116 individuals each group). In addition, 50 subjects with fibromyalgia
will be included.
Primary outcome is: (1) sitting time using the activPAL device and the Marshall questionnaire. The following
parameters will be also assessed: (2) sitting time in work place (Occupational Sitting and Physical Activity
Questionnaire), (3) health-related quality of life (EQ-5D), (4) evolution of stage of change (Prochaska and DiClemente's
Stages of Change Model), (5) physical inactivity (catalan version of Brief Physical Activity Assessment Tool), (6) number
of steps walked (pedometer and activPAL), (7) control based on analysis (triglycerides, total cholesterol, HDL, LDL,
glycemia and, glycated haemoglobin in diabetic patients) and (8) blood pressure and anthropometric variables.
All parameters will be assessed pre and post intervention and there will be a follow up three, six and twelve months
after the intervention. A descriptive analysis of all variables and a multivariate analysis to assess differences among
groups will be undertaken. Multivariate analysis will be carried out to assess time changes of dependent variables. All
the analysis will be done under the intention to treat principle.
Discussion: If the SEDESTACTIV intervention shows its effectiveness in reducing sitting time, health professionals would
have a low-cost intervention tool for sedentary overweight and obese patients management.
Trial registration: A service of the U.S. National Institutes of Health. Developed by the National Library of Medicine.
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Obesity is one of the main leading cause of mortality
worldwide; in fact according to the World Health
Organization (WHO) more than 2.8 million adults die
each year because they are obese or overweight. In
addition, is one of the main risk factor for many of the
leading causes of mortality such as cardiovascular dis-
eases, stroke and certain cancers [1]. The percentage of
obese and overweight people worldwide has significantly
risen in the past years [2]. Therefore, prevention and re-
duction of obesity should be a public health priority and
mainly include: rising physical activity (PA), lowering
sedentary behavior (SB) and modifying the diet to low-
calorie and low-fat diets [3].
Sedentary behavior is any waking behavior character-
ized by an energy expenditure ≤1.5 Metabolic Equivalent
Units (METs) while in a sitting or reclining posture [4].
Recently, a range of observational data has reported
associations between sedentary time and adverse health
outcomes [5], including an increased risk of diabetes,
cardiovascular and all-cause mortality [6-8].
Lifestyle changes in high-income countries have led to
a decrease in the energy expenditure needed for daily
life, an increase in sedentary activities and weight gain.
Levels of PA and sedentary behavior among young people
tend to promote obesity [9].
The dose–response relationship among amount of PA,
energy expenditure and weight loss is obvious [10]. People
with overweight and obesity should accomplish 5 sessions
of 45–60 minutes of mild-intensity PA per week [11].
Unfortunately, evidence shows the difficulty of over-
weight and obese population to achieve these recom-
mendations in the long term; PA dropout among them
is quite high [12].
In this context, and considering the scarce adherence
to PA in people with overweight and obesity, there is
recent evidence that interventions to increase energy
expenditure perhaps should first focus on reducing time
of sedentary activities. It is well known that walking is
a simple PA accessible to most people, which can have
an important role to increase daily energy expenditure
and help reduce SB [13]. Moreover, if obese people
could manage to be standing or wandering for 2.5 hours
per day instead of sitting, this would represent an
extra energy expenditure of 350 kcal per day, and they
might find it easier to maintain this activity in the long
term [14].
To effectively manage the increasing number of pa-
tients with obesity-related chronic illnesses, the medical
community should embrace a major role in encouraging
patients to make healthy lifestyle choices. Primary care
is well suited to fill this need, because most of the popu-
lation identifies a primary care clinician as their usual
source of care [15].There are few randomized controlled trials that assess
the impact of interventions on the reduction in daily
sitting time. Additionally, these studies have included
small samples. A recent intervention with 92 subjects
with type-2 diabetes achieved a reduction in daily sitting
time of 23 min/day [16]. Another study with 12 patients
with overweight and obesity showed an increase in walk-
ing time per day (146 to 203 min/day), increase in num-
ber of steps/day (4351 to 7080 steps/day) and decrease
in sitting time (1238 to 1150 min/day) [17]. To our
knowledge, there is no evidence on the effectiveness of
an intervention based on reducing daily sitting time in
adults with overweight and mild obesity and its sustain-
ability in the long term.
The aim of the present study is to assess whether a
sustained reduction of sedentary time is possible, and if
so, to evaluate the effectiveness of an education-based
intervention among overweight and mild obese adults
attended in Primary Care in terms of reduction of sitting
time. Secondary aims are to determine health benefits of
the intervention among studied population.
Method/Design
The present study is a randomized controlled trial
(RCT). The intervention evaluated is education-based in
order to reduce sedestation time among overweight and
mild obese adults attending primary care. The Project
SEDESTACTIV includes two phases. Phase 1: a qualita-
tive study already undertaken to know the proposals,
barriers and facilitators of overweight or mild obesity
users of primary health care (PHC) on reducing sitting
time. Phase 2: a randomized controlled intervention trial
based on education to reduce sedentary behavior (SB).
Phase 1. Qualitative data collection and analysis
The qualitative study included focal groups and semi-
structured interviews were conducted by an expert mod-
erator and an observer in PHC. 22 overweight or mild
obese aged 25–65 years who were 6 or more hours
sitting (see study population) participated. Awareness,
acceptability and readiness to reduce sedentary behavior
(according to importance, motivation and confidence)
and opinions about primary care interventions to reduce
sitting time were discussed. Facilitators and barriers for
change were also asked. The number of subjects was
determined by the saturation of the information (n = 22).
All participants read and signed the informed consent
form. All interviews were recorded, transcribed and
analyzed using Atlas.ti, performing a triangulation of ana-
lysis. Ethical approval was granted by Clinical Investigation
Ethics Committee of the IDIAP Jordi Gol, located in
Barcelona.
Qualitative data was used to design the RCT education
intervention to reduce sitting time. From these findings
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SB in overweight and mild obesity people should include
monitoring by a professional and face-to-face follow-up.
Phase 2. Randomized controlled trial (RCT)
Phase 2 consist of a multi-centric RCT to assess the
effectiveness of a six-month primary care intervention to
reduce the daily hours of sedestation as well as to
increase their weekly caloric spend at the end of the
intervention and at short, medium and long term among
overweight and mild obese persons. The CONSORT
(Consolidated Standards of Reporting Trials) guidelines
for RCT were used to design the study and will be used
to conduct it [18].
Study population
Inclusion criteria of participants will include: (a) men
and women aged 25–65 seen at the PHC for whatever
reason; (b) diagnosed of being overweight or suffer mild
obesity (BMI: 25–34.9 kg/m2); (c) autonomous subjects
who have minimum physical aptitudes to follow the
recommendations (being able to walk and stand up
from a chair independently); (d) who are ≥6 hours daily
sitting; and (e) who can assure its participation in the
study for a year.
Exclusion criteria will be based on certain medical
conditions which could contraindicate the fulfillment of
the intervention. Patients who have had obesity surgery
will be also excluded.
Written informed consent will be obtained from all
subjects of both intervention (IG) and control group (CG)
prior to its inclusion on the study. This trial was approved
by the Clinical Investigation Ethics Committee of the
IDIAP Jordi Gol and registered at trial NCT01729936.
Recruitment process and randomisation
Recruitment will take place in 13 PHC in different regions
of Spain (Barcelona, Lleida, Zaragoza and Almeria). Pri-
mary health care professionals, who were selected on a
voluntary basis from each of the participating centers,
were trained. During the recruitment period, the oppor-
tunity to participate in the study will be offered at least
once a week to all patients with overweight or mild obes-
ity. A total of 30 subjects will be recruited in each PHC.
Patients who meet the inclusion criteria and agree to par-
ticipate will be contacted and informed about how the
project will be carried out. All of them will be requested
to sign the informed consent form to take part in the
study. Demographic and health data will be recorded
for all participants.
Random sequence generation will be computer-
generated by an independent researcher, guaranteeing
that the allocation groups remain confidential. Partici-
pants will be randomized to intervention group (IG) orcontrol group (CG) after baseline measures assessment.
Figure 1 shows the flowchart of participants’ recruitment
and trial design.
Description of the intervention
Intervention group
The intervention will be done according to the patient’s
willingness to reduce sitting time (stage of change), and
considering whether the subject prefers a more or less
intensive intervention: (a) precontemplative (not thinking
about change) and contemplative (thinking about change),
(b) ready to change with minimum professional support,
or (c) ready to change with intensive professional support.
All of them will be handed a card with the planned
sessions and Mediterranean diet recommendations.
Precontemplative and contemplative patients (a) will
be informed of the risks of being 6 or more hours sitting
and will be asked about the importance and confidence
for change. Ready to change patients (b and c) will be
proposed an intervention based on 2–5 meetings (visits
face-to-face or phone calls depending on the situation of
each professional and patient) with a trained professional
during 6 months. On those meetings, the professional
will work on finding alternatives to progressively reduce
SB by developing the same activities walking.
Control group
Subjects assigned to the control group will be given
information on the study and will be asked to continue
their routine daily activities. They will receive their usual
care from their primary care practice. Furthermore, the
health professional will give the patient pamphlet with
the Mediterranean diet recommendations. They will be
followed at the end of intervention and at three, six and
twelve months follow-up. At the following visits several
parameters will be evaluated (see Outcome measures).
Blinding – single blind
Baseline measures will be taken prior to allocation of
randomisation. Independent investigators assessing par-
ticipants at the end of the intervention and at three, six
and 12 month follow-up visits or phone calls will be
blind to the allocation of the treatment group. Partici-
pants will be asked not to discuss group allocation with
the assessing professional. Moreover, the person who




The primary outcome is sitting time measured by using
the activPAL device (PAL technologies, UK). It also will
be measured with the Marshall questionnaire [19]. The





3, 6, 12 month 
follow-up 






Invitation to participate in 2012 (n=74 PHC)
Replies received and the trial presented (n=27)
No reply (n=47)
First 13 PHC which volunteered to participate
Patients invited to participate during June 2013 through 
February 2014 (n=)
Excluded (n=)
Did not meet inclusion criteria (n=)
Unwilling to participate (n=)
Preliminary assessment (n=)
Excluded due to unwilling to participate 
(n=)
Randomised (n=)
Allocated to intervention (n=)
Attended to post-intervention assessment 
(n=)
Reasons for not answering:
Dropped out (n=)
Unable to contact (n=)
Allocated to control (n=)
Received usual care
Attended to 3, 6, 12 month, follow up (n=)
Reasons for not answering:
Dropped out (n=)
Unable to contact (n=)
Attended to post-intervention assessment 
(n=)
Reasons for not answering:
Dropped out (n=)
Unable to contact (n=)
Attended to 3, 6, 12 month, follow up (n=)
Reasons for not answering:
Dropped out (n=)
Unable to contact (n=)
Figure 1 Flowchart of participant’s recruitment and trial design.
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follow-up.
Sitting time will be evaluated, moving from ≥6 hours
daily sitting to less sitting time, and increasing the weekly
number of METs. The activPAL enables to evaluate
caloric expenditure, time sitting/lying, number of steps,
standing time, walking time and the transitions from one
position to another. This instrument has shown good val-
idity and reliability in general population in a previous
study [20]. Marshall questionnaire enables sitting time to
be evaluated as a continuous variable by calculating the
weekly minutes sitting, and classifying the subjects ac-
cording to whether they are more or less hours sitting.
This instrument has shown good validity and reliability in
general population in a previous study [19].
Other specific objectives
Secondary outcomes for IG and CG include: (a) decreasing
sitting time in work place in individuals involved in theintervention, measured with Occupational Sitting and
Physical Activity Questionnaire (OSPAQ) [21]; (b) descrip-
tion of the development of health-related quality of life
measured with EQ-5D (Euroqool Group: http://www.
euroqol.org) (first and last session of the intervention,
with follow up at three, six and twelve months after the
intervention); (c) evaluation the evolution of the attitude
towards the change in behaviours in relation to reduce
sitting time using the Prochaska scale (Prochaska and
DiClemente’s Stages of Change Model) [22]; (d) evalu-
ation of physical inactivity, assessed with catalan version
of Brief Physical Activity Assessment Tool (CBPAAT).
The CBAFC enables physical inactivity as a categoric out-
come and classifies subjects as ‘active enough’ or ‘insuffi-
ciently active’. This instrument showed good validity and
reliability in general population in a previous study [23];
(e) evaluation of the number of daily steps walked, mea-
sured with DigiWalker 200w pedometer and activPAL
posture monitor. Reliability and validity of these devices
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thropometric variables: BMI, triceps skinfold and waist
circumference; and (g) description of the evolution of
triglycerides, total cholesterol, HDL, LDL, glycemia and,
glycated haemoglobin in diabetic patients (first and last
session and 6 and 12 months after the intervention).
All parameters (not (g) outcome) will be assessed pre
and post intervention in both groups and there will be a
follow up in a face to face interview three, six and twelve
months after the intervention.
Sociodemographic and health data will be also col-
lected (age, marital status, educational level, blood pres-
sure, BMI and associated pathologies).
Data management and quality assurance
Data will be entered directly into an online question-
naire (SurveyMonkey: https://es.surveymonkey.com) by
investigators at the time of the interview and baseline
testing. Daily backups will be performed and transferred
to the master database at least once a week. Random
checks of data entry will be performed regularly and cor-
rections made will be possible by checking against elec-
tronic records and by phoning professionals for patient’s
information confirmation by independent investigators.
Sample size
Since no previous intervention studies on caloric spend
had been undertaken –similar studies report sedestation
time- we consider that the current intervention is analo-
gous to others proposed in other lifestyles such as to-
bacco consumption. Accepting an alpha risk of 0.05 and
a beta risk < 0.10 in a bilateral contrast, 232 individuals
are needed: 116 individuals in the IG and 116 in the CG
in order to detect a difference ≥ 0.15 between the two. A
proportion of 0.5 in one of the groups is to be assumed.
A dropout rate of 20% is estimated. The sample size
calculations were performed with the Granmo program
(version 7.1).
Statistical methods
Analysis of effectiveness will be made followed by the
intention to treat analysis. Descriptive statistics will be
computed as customary [25,26]. Control and interven-
tion groups will be checked for health and outcome
measures and a baseline comparability analysis of the
CG and IG in relation to the variables studied, will be
carried out. An t-Student test or ANOVA will be used in
the comparison of means if the variables follow a normal
distribution and the U of Mann Whitney if they do not.
For the other dimensions of the analysis, a covariance ana-
lysis (ANCOVA) for repeated measures will be carried out.
Multi-variate analysis will evaluate the change in the
time of the described dependent variables, and compari-
sons between the CG and IG will be established. To dothis multilevel linear models will be adjusted, one for
each dependent variable. In the first level the individual
path or the evolution of each individual over a long
period of time (pre-post intervention, 3, 6 and 12 month
follow- up) will be modelled. In the second level it will
be adjusted according to the variables that refer to the
individual; the intervention variable will be added
(intervention or control) to the independent variables
described earlier.
The level of statistical significance will be set at 0.05, and
all tests will be two-tailed. Statistical analyses will be con-
ducted using SPSS, version 17.0 (SPSS Inc, Chicago, IL).
Ethical approval
The study will be carried out according to the principles
of the “Declaration of Helsinki” and subsequent revisions
[27]. This study was reviewed and approved by the
Clinical Investigation Ethics Committee of the IDIAP
Jordi Gol, located in Barcelona. The participation of the
subjects is strictly voluntary and withdrawal will not
have any consequence on the management of their ill-
ness which will be carried out by their doctor strictly
following the accepted international norms. The data
will be treated with utmost confidentiality according to
the Organic Law which regulates the confidentiality of
computerized data (Protection of personal information
Law 15/1999), and will be used exclusively for the pur-
poses of this scientific investigation.
Discussion
Sedentary behaviour (SB) in general and sitting time in
particular is increasingly recognised as a health risk be-
haviour. Evidence suggests that SB is associated with
increased cardiovascular disease, diabetes, obesity and
mortality independent from physical activity (PA) level
[6,7]. Overweight and obese people are more sedentary
(they spend more hours sitting each day). In addition,
they have shown poor rates of change and adherence to
PA [28,29]. Thus, prevention and reduction of obesity
should be a public health priority, and reducing SB could
be an appropriate strategy [3].
Primary care centers (PHC) are an ideal setting to
identify adults who spend extended periods of daily sit-
ting, and to treat people with overweight and mild obesity.
Furthermore, are a key scene to initiate a cost-effective SB
intervention. PHC practitioners can play an important
role in population health throughout lifestyle promotion
[30]. A high percentage of the population visit their pri-
mary care professional at least once a year [31] and
tend to have confidence with them. Research has shown
that PHC practitioners’ suggestions have a high impact
in patients’ everyday life [32].
Encouraging overweight and mild obese patients to re-
duce sitting time could be the first step to increase their
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controlled trials (RCT) that had assessed the impact of
interventions on the reduction in daily sitting time. Add-
itionally, these studies have included small samples. RCT
to reduce SB in sedentary patients based on objective
measures to assess daily sitting time are needed.
SEDESTACTIV is a RCT based on a PHC intervention
carried out by a healthcare practitioner to assess whether
a sustained reduction of sitting time among overweight
and mild obese adults is possible, and if so, to evaluate
the effectiveness in determining health benefits among the
studied population. The design of the SEDESTACTIV
study takes advantage of the direct contact and accessibil-
ity of PHC with patients.
Figure 1 shows the consolidated standards of reporting
trials (CONSORT) flow diagram.
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